BOSTON SCIENTIFIC (BSX BE) stock market data APIs
€81.901
0(0%)
as of December 23, 2025
Try our APIs with
free plan!
BOSTON SCIENTIFIC Financial Data Overview
Price chart is built with
Anychart
There is no Profile data available for BSX.BE.
Prev. Close
81.901
Open
81.901
High
81.901
Low
81.901
52 wk Range
76.6-102
Market Cap
51 948 M
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get BOSTON SCIENTIFIC data using free add-ons & libraries
Get BOSTON SCIENTIFIC Fundamental Data
BOSTON SCIENTIFIC Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
BOSTON SCIENTIFIC News
New
A Strong Growth Profile Gives Boston Scientific Corp. (BSX) a Favorable Outlook
Hardman Johnston Global Advisors, an investment management company, released its “Hardman Johnston Global Equity Strategy” investor letter for the third quarter of 2025. A copy of the letter can ...
What Analysts Think Is Changing In The Boston Scientific Growth Story
Boston Scientific's latest narrative update reflects only a subtle recalibration, with the fair value estimate nudging from about $126.48 to $125.86 per share as revenue growth expectations edge highe...
Should New Institutional Support and Analyst Optimism Around Farapulse Reshape Boston Scientific (BSX) Investors’ Thesis?
In recent months, Parnassus Core Equity Fund disclosed a new position in Boston Scientific, while TD Cowen reiterated its positive stance and named the medical device maker its “Best Idea for 2026,�...
Boston Scientific (BSX): Assessing Valuation After a Strong Multi‑Year Run and Recent Pullback
Boston Scientific (BSX) has quietly outperformed many medtech peers this year, and with the stock hovering near 96 dollars after a modest pullback, investors are asking whether this long term compound...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
